The search for host genetic factors of HIV/AIDS pathogenesis in the post-genome era: Progress to date and new avenues for discovery

被引：18

作者：

Aouizerat B.E.

Pearce C.L. ^{[1
]}

Miaskowski C. ^{[2
]}

机构：

[1] Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles

[2] Department of Physiological Nursing, University of California San Francisco, San Francisco

来源：

Current HIV/AIDS Reports | 2011年 / 8卷 / 1期

基金：

美国国家卫生研究院;

关键词：

Disease progression; Genome-wide association study; GWAS; Single nucleotide polymorphism; SNP; Viral load set point;

D O I：

10.1007/s11904-010-0065-1

中图分类号：

学科分类号：

摘要：

Though pursuit of host genetic factors that influence the pathogenesis of HIV began over two decades ago, progress has been slow. Initial genome-level searches for variations associated with HIV-related traits have yielded interesting candidates, but less in the way of novel pathways to be exploited for therapeutic targets. More recent genome-wide association studies (GWAS) that include different phenotypes, novel designs, and that have examined different population characteristics suggest novel targets and affirm the utility of additional searches. Recent findings from these GWAS are reviewed, new directions for research are identified, and the promise of systems biology to yield novel insights is discussed. © 2011 The Author(s).

引用

页码：38 / 44

页数：6

共 38 条

[21]

Moore J.H., Asselbergs F.W., Williams S.M., Bioinformatics challenges for genome-wide association studies, Bioinformatics, 26, 4, pp. 445-455

[22]

Dickson S.P., Wang K., Krantz I., Hakonarson H., Goldstein D.B., Rare variants create synthetic genome-wide associations, PLoS Biol, 8, 1

[23]

Bisgrove D., Lewinski M., Bushman F., Verdin E., Molecular mechanisms of HIV-1 proviral latency, Expert Review of Anti-Infective Therapy, 3, 5, pp. 805-814, (2005)

[24]

Muthen B.O., Muthen L.K., Integrating person-centered and variable-centered analyses: Growth mixture modeling with latent trajectory classes, Alcoholism: Clinical and Experimental Research, 24, 6, pp. 882-891, (2000)

[25]

Vidal F., Gutierrez F., Gutierrez M., Olona M., Sanchez V., Mateo G., Peraire J., Vilades C., Veloso S., Lopez-Dupla M., Domingo P., Pharmacogenetics of adverse effects due to antiretroviral drugs, AIDS Rev, 12, 1, pp. 15-30

[26]

Bernard L., Vuagnat A., Peytavin G., Hallouin M.-C., Bouhour D., Nguyen T.H., Vilde J.L., Bricaire F., Raguin G., De Truchis P., Ghez D., Duong M., Perronne C., Relationship between levels of indinavir in hair and virologic response to highly active antiretroviral therapy, Annals of Internal Medicine, 137, 8, pp. 656-659, (2002)

[27]

Duval X., Peytavin G., Breton G., Ecobichon J.-L., Descamps D., Thabut G., Leport C., Hair versus plasma concentrations as indicator of indinavir exposure in HIV-1-infected patients treated with indinavir/ritonavir combination, AIDS, 21, 1, pp. 106-108, (2007)

[28]

Gandhi M., Ameli N., Bacchetti P., Gange S.J., Anastos K., Levine A., Hyman C.L., Cohen M., Young M., Huang Y., Greenblatt R.M., Women's Interagency HIVS. Protease inhibitor levels in hair strongly predict virologic response to treatment, AIDS, 23, 4, pp. 471-478, (2009)

[29]

Mothe B., Perez I., Domingo P., Podzamczer D., Ribera E., Curran A., Vilades C., Vidal F., Dalmau D., Pedrol E., Negredo E., Molto J., Paredes R., Perez-Alvarez N., Gatell J.M., Clotet B., HIV-1 infection in subjects older than 70: A multicenter cross-sectional assessment in Catalonia, Spain, Curr HIV Res, 7, 6, pp. 597-600, (2009)

[30]

Volberding P.A., Deeks S.G., Antiretroviral therapy and management of HIV infection, Lancet, 376, 9734, pp. 49-62

← 1 2 3 4 →